Ranibizumab

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 7578 publications

Comparison of adverse events of three anti-VEGF drugs for the treatment of age-related macular degeneration.

Comparison of adverse events of three anti-VEGF drugs for the treatment of age-related macular degeneration.

Journal: The Malaysian journal of pathology

Published: August 31, 2026

Early visual response provides additional prognostic value beyond baseline OCT features in diabetic macular edema.

Early visual response provides additional prognostic value beyond baseline OCT features in diabetic macular edema.

Journal: European journal of ophthalmology

Published: August 22, 2026

Real-world retinal vasculitis events reported with FDA-approved intravitreal anti-VEGF and complement inhibitor agents: an analysis of FAERS data.

Real-world retinal vasculitis events reported with FDA-approved intravitreal anti-VEGF and complement inhibitor agents: an analysis of FAERS data.

Journal: Retina (Philadelphia, Pa.)

Published: August 21, 2026

Functional and Anatomic Outcomes at 12 Months After Switching to Faricimab in Treatment-Recalcitrant Neovascular Age-Related Macular Degeneration.

Functional and Anatomic Outcomes at 12 Months After Switching to Faricimab in Treatment-Recalcitrant Neovascular Age-Related Macular Degeneration.

Journal: Journal of vitreoretinal diseases

Published: August 20, 2026

Association Between Anti-vascular Endothelial Growth Factor Therapy Exposure and Visual Outcomes in Diabetic Macular Edema and Retinal Vein Occlusion.

Association Between Anti-vascular Endothelial Growth Factor Therapy Exposure and Visual Outcomes in Diabetic Macular Edema and Retinal Vein Occlusion.

Journal: Journal of visualized experiments : JoVE

Published: August 18, 2026

Optical Coherence Tomography Biomarkers in Diabetic Macular Edema and Their Role in Predicting Visual Outcome After Ranibizumab or Triamcinolone Injection.

Optical Coherence Tomography Biomarkers in Diabetic Macular Edema and Their Role in Predicting Visual Outcome After Ranibizumab or Triamcinolone Injection.

Journal: Cureus

Published: July 29, 2026

Optic Nerve Alterations Following Intravitreal Injection and Laser in Infants With Retinopathy of Prematurity.

Optic Nerve Alterations Following Intravitreal Injection and Laser in Infants With Retinopathy of Prematurity.

Journal: Investigative ophthalmology & visual science

Published: July 23, 2026

Intravitreal Steroid and Anti-VEGF in Macular Edema Secondary to Retinal Vein Occlusion.

Intravitreal Steroid and Anti-VEGF in Macular Edema Secondary to Retinal Vein Occlusion.

Journal: Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti

Published: July 22, 2026

Community-Level Variation in On-Label Versus Off-Label Anti-VEGF Use and Medicare Part B Spending.

Community-Level Variation in On-Label Versus Off-Label Anti-VEGF Use and Medicare Part B Spending.

Journal: Retina (Philadelphia, Pa.)

Published: July 21, 2026

Ocular Decompression Retinopathy Followed by Central Retinal Vein Occlusion After Augmented Trabeculectomy in Pseudoexfoliative Glaucoma: A Case Report.

Ocular Decompression Retinopathy Followed by Central Retinal Vein Occlusion After Augmented Trabeculectomy in Pseudoexfoliative Glaucoma: A Case Report.

Journal: Cureus

Published: July 19, 2026

Treatment of spontaneous hyphema in Fuch's heterochromic iridocyclitis with intravitreal anti-VEGF ranibizumab.

Treatment of spontaneous hyphema in Fuch's heterochromic iridocyclitis with intravitreal anti-VEGF ranibizumab.

Journal: BMJ case reports

Published: July 17, 2026

Reactivation of Choroidal Neovascularization in Bilateral Punctate Inner Choroidopathy: A Case Report.

Reactivation of Choroidal Neovascularization in Bilateral Punctate Inner Choroidopathy: A Case Report.

Journal: Cureus

Published: July 14, 2026

Showing 1-12 of 7,578

Last Updated: 09/26/2026